Fluconazole structure
|
Common Name | Fluconazole | ||
---|---|---|---|---|
CAS Number | 86386-73-4 | Molecular Weight | 306.271 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | 579.8±60.0 °C at 760 mmHg | |
Molecular Formula | C13H12F2N6O | Melting Point | 138-140°C | |
MSDS | Chinese USA | Flash Point | 304.4±32.9 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of FluconazoleFluconazole is a triazole antifungal drug used in the treatment and prevention of superficial and systemic fungal infections.Target: AntifungalFluconazole is a triazole antifungal intended for oral treatment of superficial and systemic mycoses. In tests done in standard mycological media, the compound had minimal inhibitory concentrations against pathogenic Candida species that were usually in excess of 100 mg/l. Fluconazole inhibited branching and hyphal development in C. albicans at concentrations as low as 10(-6) M (0.3 mg/l), but miconazole and ketoconazole were still active in these tests at concentrations 100 times lower than this [1]. Oral fluconazole was not associated with a significantly increased risk of birth defects overall or of 14 of the 15 specific birth defects of previous concern. Fluconazole exposure may confer an increased risk of tetralogy of Fallot [2]. Fluconazole is predicted to be ineffective against Cryptococcus gattii in the koala as a sole therapeutic agent administered at 10 mg/kg p.o. every 12 h [3].Clinical indications: Balanitis; Candida infection; Cryptococcus infection; Cryptococcus neoformans meningitis; Dermatomycosis; Female genital tract infection; Fungal infection; Fungal respiratory tract infection; Fungal urinary tract infection; Prophylaxis; Tinea capitis; Tinea corporis; Tinea cruris; Tinea pedis .Toxicity: Symptoms of overdose include hallucinations and paranoid behavior. |
Name | fluconazole |
---|---|
Synonym | More Synonyms |
Description | Fluconazole is a triazole antifungal drug used in the treatment and prevention of superficial and systemic fungal infections.Target: AntifungalFluconazole is a triazole antifungal intended for oral treatment of superficial and systemic mycoses. In tests done in standard mycological media, the compound had minimal inhibitory concentrations against pathogenic Candida species that were usually in excess of 100 mg/l. Fluconazole inhibited branching and hyphal development in C. albicans at concentrations as low as 10(-6) M (0.3 mg/l), but miconazole and ketoconazole were still active in these tests at concentrations 100 times lower than this [1]. Oral fluconazole was not associated with a significantly increased risk of birth defects overall or of 14 of the 15 specific birth defects of previous concern. Fluconazole exposure may confer an increased risk of tetralogy of Fallot [2]. Fluconazole is predicted to be ineffective against Cryptococcus gattii in the koala as a sole therapeutic agent administered at 10 mg/kg p.o. every 12 h [3].Clinical indications: Balanitis; Candida infection; Cryptococcus infection; Cryptococcus neoformans meningitis; Dermatomycosis; Female genital tract infection; Fungal infection; Fungal respiratory tract infection; Fungal urinary tract infection; Prophylaxis; Tinea capitis; Tinea corporis; Tinea cruris; Tinea pedis .Toxicity: Symptoms of overdose include hallucinations and paranoid behavior. |
---|---|
Related Catalog | |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 579.8±60.0 °C at 760 mmHg |
Melting Point | 138-140°C |
Molecular Formula | C13H12F2N6O |
Molecular Weight | 306.271 |
Flash Point | 304.4±32.9 °C |
Exact Mass | 306.104065 |
PSA | 81.65000 |
LogP | 0.50 |
Vapour Pressure | 0.0±1.7 mmHg at 25°C |
Index of Refraction | 1.663 |
Storage condition | −20°C |
Water Solubility | DMSO: 5 mg/mL |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xn: Harmful; |
Risk Phrases | R36/37/38 |
Safety Phrases | S26-S36 |
RIDADR | NONH for all modes of transport |
RTECS | XZ4810000 |
HS Code | 2933990090 |
~66% Fluconazole CAS#:86386-73-4 |
Literature: Zhang, Yi-Yi; Mi, Jia-Li; Zhou, Cheng-He; Zhou, Xiang-Dong European Journal of Medicinal Chemistry, 2011 , vol. 46, # 9 p. 4391 - 4402 |
~96% Fluconazole CAS#:86386-73-4 |
Literature: CENTRO GENESIS PARA LA INVESTIGACION, S.L. Patent: EP967210 A1, 1999 ; |
~% Fluconazole CAS#:86386-73-4 |
Literature: US5484936 A1, ; |
~26%
Detail
|
Literature: Pfizer Inc. Patent: US4404216 A1, 1983 ; |
~67% Fluconazole CAS#:86386-73-4 |
Literature: Chen, Same-Ting; Fang, Jim-Min Journal of the Chinese Chemical Society, 2003 , vol. 50, # 4 p. 927 - 930 |
~% Fluconazole CAS#:86386-73-4 |
Literature: Journal of the Chinese Chemical Society, , vol. 50, # 4 p. 927 - 930 |
~% Fluconazole CAS#:86386-73-4 |
Literature: European Journal of Medicinal Chemistry, , vol. 46, # 9 p. 4391 - 4402 |
~% Fluconazole CAS#:86386-73-4 |
Literature: European Journal of Medicinal Chemistry, , vol. 46, # 9 p. 4391 - 4402 |
~% Fluconazole CAS#:86386-73-4 |
Literature: Journal of Heterocyclic Chemistry, , vol. 30, # 5 p. 1405 - 1412 |
Precursor 10 | |
---|---|
DownStream 6 | |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Antifungal susceptibility and virulence attributes of animal-derived isolates of Candida parapsilosis complex.
J. Med. Microbiol. 63(Pt 11) , 1568-72, (2014) This study aimed to identify strains of the Candida parapsilosis complex isolated from animals, as well as to assess their in vitro antifungal susceptibility profile and in vitro production of virulen... |
|
Simultaneous determination of seven azole antifungal drugs in serum by ultra-high pressure liquid chromatography and diode array detection.
Acta Clin. Belg. 69(1) , 53-61, (2014) Azole antifungals are a group of fungistatic agents that can be administered orally or parenterally. The determination of the concentrations of these antifungals (miconazole, fluconazole, ketoconazole... |
|
Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
Cochrane Database Syst. Rev. 3 , CD003478, (2013) Invasive fungal infection is an important cause of mortality and morbidity in very preterm or very low birth weight infants. Uncertainty exists about the effect of prophylactic oral/topical non-absorb... |
2-(2,4-Difluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)-2-propanol |
triflucan |
Flunazol |
Apo Fluconazole |
FluMycon |
α-(2,4-Difluorophenyl)-α-(1H-1,2,4-triazol-1-ylmethyl)-1H-1,2,4-triazole-1-ethanol |
Zonal |
2-(2,4-Difluorphenyl)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol |
Apo-Fluconazole |
2,4-Difluoro-a,a-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl Alcohol |
Diflucan |
Zoltec |
Difluean |
1H-1,2,4-Triazole-1-ethanol, α-(2,4-difluorophenyl)-α-(1H-1,2,4-triazol-1-ylmethyl)- |
2-(2,4-Difluorphenyl)-1,3-di-1H-1,2,4-triazol-1-ylpropan-2-ol |
a-(2,4-Difluorophenyl)-a-(1H-1,2,4-triazol-1-ylmethyl)-1H-1,2,4-triazole-1-ethanol |
2-(2,4-difluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol |
Fluconazole |
EINECS 200-659-6 |
1H-1,2,4-triazole-1-ethanol, a-(2,4-difluorophenyl)-a-(1H-1,2,4-triazol-1-ylmethyl)- |
Diflazon |
MFCD00274549 |
Flusol |
Elazor |
Flucostat |
Fluconal |
2-(2,4-DIFLUOROPHENYL)-1,3-BIS-(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL |